Literature DB >> 8321430

Effects of stimulation of dopamine D1 receptors on the cortical EEG in rats: different influences by a blockade of D2 receptors and by an activation of putative dopamine autoreceptors.

W Kropf1, K Kuschinsky.   

Abstract

The effects of a stimulation of dopamine D1 receptors by using (+/-)SKF 38393 on the cortical EEG in rats which were chronically implanted with electrodes were studied. Administration of SKF 38393 (3 or 9 mg/kg, s.c.) produced alterations suggesting an arousal in the EEG: the power in all of the frequency bands decreased to a level of 70-80% of baseline activity, which effect was dose- and time-dependent. In behaviour, episodes of intensive grooming (face-washing) alternated with those of lack of spontaneous motility and occasionally chewing movements were noted. In contrast, apomorphine (0.5 mg/kg, s.c.) produced a selective increase in power in the alpha 1 band, accompanied by stereotyped sniffing and licking. The effects of SKF 38393 (9 mg/kg) were completely blocked by pretreatment with the selective antagonist at D1 dopamine receptors, SCH 23390 (0.2 mg/kg, i.p.). The application of haloperidol (0.1 mg/kg, i.p.), which is mainly a D2 blocker, failed to influence the alterations induced by SKF 38393 (9 kg/kg, s.c.). In a further experimental group, the effects produced by stimulation of D1 receptors (SKF 38393 9 mg/kg), followed by activation of putative dopamine autoreceptors by a small dose of apomorphine (0.05 mg.kg, s.c.) were studied: in this case, the effects of SKF 38393 were abolished and typical effects of small doses of apomorphine were manifest, such as hypokinesia and sedation, accompanied by large increases of power in all of the frequency bands, except beta 2. The results suggest that stimulation of D1 receptors produces some desynchronization in the EEG.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8321430     DOI: 10.1016/0028-3908(93)90175-3

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  7 in total

1.  Role of dopamine receptors on electroencephalographic changes produced by repetitive apomorphine treatments in rats.

Authors:  Hwan Soo Jang; Ji Young Kim; Sang Heon Kim; Maan-Gee Lee
Journal:  Korean J Physiol Pharmacol       Date:  2009-06-30       Impact factor: 2.016

2.  Effects of cocaine on the EEG power spectrum of rats are significantly altered after its repeated administration: do they reflect sensitization phenomena?

Authors:  B Ferger; D Stahl; K Kuschinsky
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-04       Impact factor: 3.000

3.  Studies on electroencephalogram (EEG) in rats suggest that moderate doses of cocaine or d-amphetamine activate D1 rather than D2 receptors.

Authors:  B Ferger; W Kropf; K Kuschinsky
Journal:  Psychopharmacology (Berl)       Date:  1994-03       Impact factor: 4.530

4.  The effects of dexamphetamine on the resting-state electroencephalogram and functional connectivity.

Authors:  Matthew A Albrecht; Gareth Roberts; Greg Price; Joseph Lee; Rajan Iyyalol; Mathew T Martin-Iverson
Journal:  Hum Brain Mapp       Date:  2015-11-18       Impact factor: 5.038

5.  The role of the nucleus accumbens and rostral anterior cingulate cortex in anhedonia: integration of resting EEG, fMRI, and volumetric techniques.

Authors:  Jan Wacker; Daniel G Dillon; Diego A Pizzagalli
Journal:  Neuroimage       Date:  2009-02-06       Impact factor: 6.556

6.  Activation of dopamine D1 receptors or alpha 1 adrenoceptors is not involved in the EEG effect of nicotine in rats.

Authors:  B Ferger; K Kuschinsky
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-10       Impact factor: 3.000

7.  Roles of adrenergic α1 and dopamine D1 and D2 receptors in the mediation of the desynchronization effects of modafinil in a mouse EEG synchronization model.

Authors:  Chang-Rui Chen; Su-Rong Yang; Yuan-Yuan Liu; Wei-Min Qu; Yoshihiro Urade; Zhi-Li Huang
Journal:  PLoS One       Date:  2013-10-07       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.